Arama Sonuçları Antibodies. - Daraltılmış: Oncology.
SirsiDynix Enterprise
https://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dAntibodies.$0026qf$003dSUBJECT$002509Konu$002509Oncology.$002509Oncology.$0026ic$003dtrue$0026ps$003d300$0026isd$003dtrue?dt=list
2025-03-19T11:19:32Z
Bispecific Antibodies
ent://SD_ILS/0/SD_ILS:194528
2025-03-19T11:19:32Z
2025-03-19T11:19:32Z
Yazar Kontermann, Roland E. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="http://dx.doi.org/10.1007/978-3-642-20910-9">http://dx.doi.org/10.1007/978-3-642-20910-9</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>
Therapeutic Antibodies
ent://SD_ILS/0/SD_ILS:186792
2025-03-19T11:19:32Z
2025-03-19T11:19:32Z
Yazar Chernajovsky, Yuti. editor. Nissim, Ahuva. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="http://dx.doi.org/10.1007/978-3-540-73259-4">http://dx.doi.org/10.1007/978-3-540-73259-4</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
ent://SD_ILS/0/SD_ILS:401396
2025-03-19T11:19:32Z
2025-03-19T11:19:32Z
Yazar Ferreri, Andrés J. M. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-3-319-75184-9">https://doi.org/10.1007/978-3-319-75184-9</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>
Resistance to Immunotherapeutic Antibodies in Cancer Strategies to Overcome Resistance
ent://SD_ILS/0/SD_ILS:332319
2025-03-19T11:19:32Z
2025-03-19T11:19:32Z
Yazar Bonavida, Benjamin. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE(332319.1)<br/>Elektronik Erişim <a href="http://dx.doi.org/10.1007/978-1-4614-7654-2">http://dx.doi.org/10.1007/978-1-4614-7654-2</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>
Radiopharmaceutical Therapy
ent://SD_ILS/0/SD_ILS:528815
2025-03-19T11:19:32Z
2025-03-19T11:19:32Z
Yazar Bodei, Lisa. editor. Lewis, Jason S. editor. Zeglis, Brian M. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-3-031-39005-0">https://doi.org/10.1007/978-3-031-39005-0</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>
Antibody-Drug Conjugates and Immunotoxins From Pre-Clinical Development to Therapeutic Applications
ent://SD_ILS/0/SD_ILS:331777
2025-03-19T11:19:32Z
2025-03-19T11:19:32Z
Yazar Phillips, Gail Lewis. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE(331777.1)<br/>Elektronik Erişim <a href="http://dx.doi.org/10.1007/978-1-4614-5456-4">http://dx.doi.org/10.1007/978-1-4614-5456-4</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>
Drugs for HER-2-positive Breast Cancer
ent://SD_ILS/0/SD_ILS:176626
2025-03-19T11:19:32Z
2025-03-19T11:19:32Z
Yazar Sibilia, Maria. editor. Zielinski, Christoph C. editor. Bartsch, Rupert. editor. Grunt, Thomas W. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="http://dx.doi.org/10.1007/978-3-0346-0094-1">http://dx.doi.org/10.1007/978-3-0346-0094-1</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>
Metastasis of Colorectal Cancer
ent://SD_ILS/0/SD_ILS:205330
2025-03-19T11:19:32Z
2025-03-19T11:19:32Z
Yazar Beauchemin, Nicole. editor. Huot, Jacques. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="http://dx.doi.org/10.1007/978-90-481-8833-8">http://dx.doi.org/10.1007/978-90-481-8833-8</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>